Coinfección TB/VIH: Guía Clínica. Versión actualizada – 2010

Updated guidelines for the use of rifamycins for the treatment of tuberculosis
among HIV-infected patients taking protease inhibitors or nonnucleoside
reverse transcriptase inhibitors. Morbidity and Mortality Weekly
Report, 2004, 53(2):37.
Vittinghof E: Per contact risk of human immunodeficiency virus transmission
between male sexual partners. American Journal of Epidemiology
1999;150:306.
Waisman JL et al. Improved prognosis in HIV/AIDS related multi-drug
resistant tuberculosis patients treated with highly active antiretroviral
therapy] Medicina (B Aires), 2001, 61(6):810–814.
Wells CD et al. HIV infection and multidrug-resistant tuberculosis: the
perfect storm. Journal of Infectious Diseases, 2007, 196 Suppl 1:S86-
S107.
Wenzel R, Brewer T, Butzler J.P. A Guide to Infection Control in the
Hospital (3rd ed). International Society for Infectious Diseases. Boston
2004.
WHO Three I’s Meeting Report. World Health Organization, HIV
Department: Geneva, 2008.
WHO ANTIRETROVIRAL Therapy For Hiv Infection IN Infants
And Children: Towards Universal Access Recommendations for a public
health approach 2010 Revision.
WHO Guidelines for intensified tuberculosis case-finding and
isoniazid preventive therapy for people living with HIV in resourceconstrained
settings: http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf
Bibliografía 157